BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 30589090)

  • 1. Migraine Progression: A Systematic Review.
    Buse DC; Greisman JD; Baigi K; Lipton RB
    Headache; 2019 Mar; 59(3):306-338. PubMed ID: 30589090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine days decline with duration of illness in adolescents with transformed migraine.
    Bigal ME; Sheftell FD; Tepper SJ; Rapoport AM; Lipton RB
    Cephalalgia; 2005 Jul; 25(7):482-7. PubMed ID: 15955034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria.
    Bigal ME; Rapoport AM; Tepper SJ; Sheftell FD; Lipton RB
    Headache; 2005 May; 45(5):582-9. PubMed ID: 15953277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic migraine, classification, differential diagnosis, and epidemiology.
    Lipton RB
    Headache; 2011; 51 Suppl 2():77-83. PubMed ID: 21770929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.
    Serrano D; Lipton RB; Scher AI; Reed ML; Stewart WBF; Adams AM; Buse DC
    J Headache Pain; 2017 Oct; 18(1):101. PubMed ID: 28980171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results.
    Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB
    Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From migraine to chronic daily headache: the biological basis of headache transformation.
    Meng ID; Cao L
    Headache; 2007 Sep; 47(8):1251-8. PubMed ID: 17883547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study.
    Wang SJ; Fuh JL; Lu SR; Juang KD
    Neurology; 2007 Feb; 68(8):591-6. PubMed ID: 17182975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of screening with the brief headache screen compared with a modified IDMigraine.
    Maizels M; Houle T
    Headache; 2008 Mar; 48(3):385-94. PubMed ID: 18028378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML
    Headache; 2013; 53(10):1548-63. PubMed ID: 23992516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracing transformation: chronic migraine classification, progression, and epidemiology.
    Lipton RB
    Neurology; 2009 Feb; 72(5 Suppl):S3-7. PubMed ID: 19188564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic daily headache in adolescents: an 8-year follow-up study.
    Wang SJ; Fuh JL; Lu SR
    Neurology; 2009 Aug; 73(6):416-22. PubMed ID: 19605771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of chronic daily headache in children and adolescents].
    Cuvellier JC
    Rev Neurol (Paris); 2009; 165(6-7):521-31. PubMed ID: 19041108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study.
    Martin VT; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    Headache; 2016 Jan; 56(1):118-31. PubMed ID: 26581563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic migraine is an earlier stage of transformed migraine in adults.
    Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
    Neurology; 2005 Nov; 65(10):1556-61. PubMed ID: 16301481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for and Management of Medication-Overuse Headache.
    Lipton RB
    Continuum (Minneap Minn); 2015 Aug; 21(4 Headache):1118-31. PubMed ID: 26252595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for migraine disease progression: a narrative review for a patient-centered approach.
    Lipton RB; Buse DC; Nahas SJ; Tietjen GE; Martin VT; Löf E; Brevig T; Cady R; Diener HC
    J Neurol; 2023 Dec; 270(12):5692-5710. PubMed ID: 37615752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Serrano D; Pavlovic JM; Manack AN; Reed ML; Turkel CC; Buse DC
    Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of chronic daily headache in young adolescents: a school cohort study.
    Lu SR; Fuh JL; Wang SJ; Juang KD; Chen SP; Liao YC; Wang YF
    Pediatrics; 2013 Jul; 132(1):e9-e16. PubMed ID: 23776112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.